Clever Leaves Q3 Revenue Declines 18% YoY, Provides Outlook Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) Q3 2022 revenue was $3.3 million, a 18% decrease compared to $4.0 million in Q3 2021. Benzinga · Nov 10, 2022
Clever Leaves To Grow & Commercialize House Of Kush THC Flower For International Cannabis Markets Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) entered into partnership with House of Kush, to be the exclusive grower and distributor of proprietar Benzinga · Sep 21, 2022
EXCLUSIVE: Colombia Is About To Legalize Cannabis - And Exports May Land On Your Doorstep Soon, This CEO Says Andres Fajardo is the CEO of Clever Leaves Holdings Inc. (NASDAQ: CLVR), one of the largest cannabis companies with operations in Canada, Colombia, Germany, Portugal and the United States. Benzinga · Aug 9, 2022
Are Nasdaq-Traded Colombian Cannabis Stocks Worth Buying? Yes And No, Says Analyst Cantor Fitzgerald's analyst Pablo Zuanic initiated coverage on two cannabis companies on Monday: Flora Growth Corp. (NASDAQ: FLGC) and Clever Leaves Holdings Inc (NASDAQ: CLVR) Benzinga · Aug 1, 2022
Cantourage And Clever Leaves Intensify Partnership For Distribution Of Medical Cannabis In Germany Cantourage GmbH and Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) have continued to intensify their strategic partnership for the distribution of medical cannabis flowers throughout Germany. Benzinga · Jun 8, 2022
Clever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2M Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the first quarter en Benzinga · May 13, 2022
Clever Leaves Affiliate Now Fully Licensed To Distribute Medical Cannabis In Germany Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) and its affiliate in Germany, Clever Leaves Germany GmbH, have received all of the required regulatory licenses, per Benzinga · Apr 27, 2022
Clever Leaves Partners With Biom Therapeutics As Supplier Of Pharmaceutical-Grade CBD Used In Clinical Trials Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), announced a two-year supply agreement with American, clinical-stage bio-pharmaceutical company, Biom Therapeutics to provide Benzinga · Apr 20, 2022
5 Short Squeeze Candidates To Watch: Aterian And Newegg Remain In Top Two Positions, Cannabis Company Joins List Week Of 4/20 Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. Benzinga · Apr 18, 2022
Do Sundial Growers and Clever Leaves Deserve a Place in Your Cannabis Portfolio? Cannabis stocks, such as Sundial Growers (SNDL) and Clever Leaves (CLVR), are trading significantly lower compared to record highs. While the two companies might look attractive to contrarian investors, you need to take a closer look at the financials to make a long-term investment decision. StockNews.com · Mar 29, 2022
Why Is Clever Leaves Stock Surging 140%? Look To Washington DC Next Week For The Answer Stocks of Clever Leaves Holdings Inc. (NASDAQ: CLVRW) are soaring as of late Friday following reports indicating the U.S. Benzinga · Mar 25, 2022
Why Clever Leaves Stock Is Trading Higher And What Investors Need To Know Clever Leaves Holdings Inc (NASDAQ: CLVR) is trading higher Friday following reports indicating the U.S. House Rules Committee has scheduled a Monday afternoon meeting to prepare a federal marijuana legalization bill for floor action. Benzinga · Mar 25, 2022
Clever Leaves Reports Fourth Quarter And Full Year 2021 Results Clever Leaves Holdings Inc. (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the fourth quarter and full-year ended December 31, 2021. Benzinga · Mar 24, 2022
Here's Why Cannabis-Related Stock Clever Leaves Is Rising During Thursday's After-Hours Session Clever Leaves Holdings Inc (NASDAQ: CLVR) shares are trading higher by 9.5% to $1.73 during Thursday's after-hours session after the company reported better-than-expected fourth-quarter sales results and reaffirmed FY22 guidance. Benzinga · Mar 24, 2022
Benzinga · Mar 22, 2022 InterCure And Clever Leaves Enter Into International Strategic Partnership InterCure Ltd.
Benzinga · Mar 2, 2022 Clever Leaves Teams Up With FoliuMed To Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany Clever Leaves Holdings Inc. (NASDAQ: CLVR) has signed a one-year international sales agreement with German- Colombian operator FoliuMed Holdings and its German manufacturing partner, Fidelio Healthcare. With access to three of Clever Leaves’ pharmaceutical grade bulk cannabis extracts
Benzinga · Feb 28, 2022 Clever Leaves Inks $7.8M Product Deal With Australian Medical Cannabis Company Clever Leaves Holdings Inc. (NASDAQ: CLVR) has inked a four-year take or pay supply agreement with an Australian medicinal cannabis company, Australian Natural Therapeutics Group.
Benzinga · Feb 22, 2022 Clever Leaves Expands Partnership With German Cannabis Distributor Cansativa On Heels Of $15M Raise Clever Leaves Holdings Inc. (NASDAQ: CLVR) is expanding its partnership with German cannabis distributor and wholesaler Cansativa GmbH.
Benzinga · Feb 14, 2022 Cannabis Movers & Shakers: Ascend Wellness, MedMen, Clever Leaves, Palo Santo, GoldCann Ascend Wellness Promotes Frank Perullo To President Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH) has promoted its co-founder and chief strategy officer, Frank Perullo, to president.
Benzinga · Feb 14, 2022 Clever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flower Clever Leaves Holdings Inc. (NASDAQ: CLVR) announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. by signing a two-year, take-or-pay basis supply agreement.
Benzinga · Feb 9, 2022 Clever Leaves' Q4 Revenue Up 25% YoY, Introduces 2022 Outlook & New CEO Clever Leaves Holdings Inc. (NASDAQ: CLVR) reported its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook.
Benzinga · Jan 26, 2022 Clever Leaves Enters US Consumer CBD Market Via Herbal Brands' JoySol Clever Leaves Holdings Inc. (NASDAQ: CLVR), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced Wednesday that it has officially entered the U.S. CBD market through the launch of its consumer-oriented CBD line JoySol.
Benzinga · Sep 7, 2021 What Will Be The Cost Of Doing Cannabis Business in Mexico...If The Country Finally Legalizes It? Medical marijuana has been legalized in Mexico since June 2017 and, in 2018, Mexico’s Supreme Court of Justice ruled that banning the plant was unconstitutional.